Long COVID: Clinical Study on the Efficacy of the CellFasting Supplement Gets Under Way
Conducted by SoLongevity Research in collaboration with Sacco Hospital in Milan, the study will assess in more than 150 patients the efficacy of the nutraceutical on the redox state and on the symptoms of the disease, in particular on tiredness, brain fog and sleep quality.
